Congressional Portfolio Shift: Social media users highlighted a recent disclosure showing Rep. David J. Taylor adding Amgen shares to his holdings in a series of small trades executed in early June. Observers noted the move alongside purchases in utilities and telecom while exiting select tech positions, interpreting it as a preference for stable cash-flow generators.
Investor Sentiment Builds: Discussions on social media reflected measured optimism around the filing, with participants viewing the addition as a signal of confidence in the biotech sector's defensive qualities. Analysts and traders emphasized the limited size of the position yet stressed its timing amid broader market rotations.
Note: This discussion summary was generated from an AI condensation of post data.
Amgen Insider Trading Activity
Amgen insiders have traded $AMGN stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $AMGN stock by insiders over the last 6 months:
- ESTEBAN SANTOS (EVP, Operations) has made 0 purchases and 2 sales selling 54,792 shares for an estimated $20,772,595.
- NANCY A. GRYGIEL (SVP & CCO) sold 1,237 shares for an estimated $400,450
- MATTHEW C. BUSCH (VP, Finance & CAO) sold 1,000 shares for an estimated $375,790
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Amgen Revenue
Amgen had revenues of $8.6B in Q1 2026. This is an increase of 5.76% from the same period in the prior year.
You can track AMGN financials on Quiver Quantitative's AMGN stock page.
You can access data on AMGN stock through the Quiver Quantitative API.
Amgen Congressional Stock Trading
Members of Congress have traded $AMGN stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $AMGN stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 2 purchases worth up to $30,000 on 06/05, 01/16 and 2 sales worth up to $30,000 on 02/26, 01/29.
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/24 and 1 sale worth up to $50,000 on 04/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
Amgen Hedge Fund Activity
We have seen 1,402 institutional investors add shares of Amgen stock to their portfolio, and 1,438 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 11,063,995 shares (-60.8%) from their portfolio in Q1 2026, for an estimated $3,892,866,640
- CAPITAL WORLD INVESTORS added 6,190,632 shares (+26.8%) to their portfolio in Q1 2026, for an estimated $2,178,173,869
- CAPITAL RESEARCH GLOBAL INVESTORS added 2,307,190 shares (+49.6%) to their portfolio in Q1 2026, for an estimated $811,784,801
- JPMORGAN CHASE & CO removed 1,936,240 shares (-45.8%) from their portfolio in Q4 2025, for an estimated $633,750,714
- ROCKEFELLER CAPITAL MANAGEMENT L.P. removed 1,645,235 shares (-71.9%) from their portfolio in Q1 2026, for an estimated $578,875,934
- PACER ADVISORS, INC. removed 1,613,121 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $527,990,634
- GEODE CAPITAL MANAGEMENT, LLC added 1,127,230 shares (+7.9%) to their portfolio in Q1 2026, for an estimated $396,615,875
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Amgen Price Targets
Multiple analysts have issued price targets for $AMGN recently. We have seen 14 analysts offer price targets for $AMGN in the last 6 months, with a median target of $350.0.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $340.0 on 06/10/2026
- David Amsellem from Piper Sandler set a target price of $427.0 on 05/14/2026
- Vamil Divan from Guggenheim set a target price of $340.0 on 05/04/2026
- Gregory Renza from Truist Securities set a target price of $327.0 on 05/01/2026
- Gary Nachman from Canaccord Genuity set a target price of $366.0 on 04/21/2026
- Michael Yee from UBS set a target price of $400.0 on 04/13/2026
- Carter Gould from Cantor Fitzgerald set a target price of $350.0 on 04/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
